pI: 6.7092 |
Length (AA): 488 |
MW (Da): 55650 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128650)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G25757 | RNA polymerase I-associated factor PAF67 |
Arabidopsis thaliana | AT5G25754 | RNA polymerase I-associated factor PAF67 |
Babesia bovis | BBOV_III003720 | conserved hypothetical protein |
Brugia malayi | Bm1_25770 | hypothetical protein |
Cryptosporidium hominis | Chro.20128 | RE21692p |
Cryptosporidium parvum | cgd2_1160 | HSPC021/HSPC025 family protein |
Dictyostelium discoideum | DDB_G0272076 | eukaryotic translation initiation factor 3 subunit 6 interacting protein |
Drosophila melanogaster | Dmel_CG5642 | CG5642 gene product from transcript CG5642-RA |
Echinococcus granulosus | EgrG_001123900 | eukaryotic translation initiation factor 3 |
Echinococcus multilocularis | EmuJ_001123900 | eukaryotic translation initiation factor 3 |
Homo sapiens | ENSG00000100129 | eukaryotic translation initiation factor 3, subunit L |
Leishmania braziliensis | LbrM.35.0330 | EIF3-interacting protein-like protein |
Leishmania donovani | LdBPK_360270.1 | eukaryotic translation initiation factor 3 subunit l |
Leishmania infantum | LinJ.36.0270 | EIF3-interacting protein-like protein |
Leishmania major | LmjF.36.0250 | EIF3-interacting protein-like protein |
Leishmania mexicana | LmxM.36.0250 | EIF3-interacting protein-like protein |
Loa Loa (eye worm) | LOAG_00600 | eukaryotic translation initiation factor 3 subunit L |
Mus musculus | ENSMUSG00000033047 | eukaryotic translation initiation factor 3, subunit L |
Neospora caninum | NCLIV_034190 | eukaryotic translation initiation factor 3 subunit 6 interacting protein, putative |
Oryza sativa | 4338152 | Os05g0227700 |
Oryza sativa | 4327193 | Os01g0229100 |
Onchocerca volvulus | OVOC10237 |
|
Plasmodium berghei | PBANKA_0110400 | eukaryotic translation initiation factor 3 subunit L, putative |
Plasmodium falciparum | PF3D7_0612100 | eukaryotic translation initiation factor 3 subunit L, putative |
Plasmodium knowlesi | PKNH_1137900 | eukaryotic translation initiation factor 3 subunit L, putative |
Plasmodium vivax | PVX_113750 | eukaryotic translation initiation factor 3 subunit 6 interacting protein, putative |
Plasmodium yoelii | PY06519 | Drosophila melanogaster RE21692p, putative |
Schistosoma japonicum | Sjp_0056020 | Eukaryotic translation initiation factor 3 subunit E-interacting protein, putative |
Schistosoma mansoni | Smp_064530 | hypothetical protein |
Schmidtea mediterranea | mk4.002504.00 | Eukaryotic translation initiation factor 3 subunit L |
Trypanosoma brucei gambiense | Tbg972.10.5660 | EIF3-interacting protein, putative |
Trypanosoma brucei | Tb927.10.4640 | eukaryotic translation initiation factor 3 subunit l |
Trypanosoma congolense | TcIL3000_10_3850 | eukaryotic translation initiation factor 3 subunit l |
Trypanosoma cruzi | TcCLB.508169.90 | eukaryotic translation initiation factor 3 subunit l |
Trypanosoma cruzi | TcCLB.506581.30 | eukaryotic translation initiation factor 3 subunit l |
Toxoplasma gondii | TGME49_273460 | eukaryotic translation initiation factor 3 subunit 6 interacting protein |
Theileria parva | TP02_0247 | hypothetical protein, conserved |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.4640 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.4640 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.4640 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.4640 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0110400 | Plasmodium berghei | Slow | plasmo |
TGME49_273460 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.